Message #70 From:
NewsBot Date: February 28, 2007 01:05:00 PM
ABI News Applied Biosystems and Celera to Webcast Investor Meetings
FOSTER CITY, Calif. & ALAMEDA, Calif.--(BUSINESS WIRE)--Applied Biosystems Group (NYSE:ABI) and Celera Group (NYSE:CRA), Applera Corporation businesses, will webcast meetings with investors to be held at Celera’s offices in Alameda, California on March 7, 2007. The Celera meeting is scheduled to begin at 8:30 a.m. PT and end at 9:30 a.m. PT, during which Celera president Kathy Ordoñez will provide an overview of the Celera business and take questions from investors. The Applied Biosystems meeting is scheduled to begin at 10 a.m. PT and end at 11 a.m. PT, during which Laura Lauman, president of the Applied Biosystems Proteomics and Small Molecule Division and Kim Caple, senior director and general manager of the Applied Biosystems Genetic Analysis business, will discuss their businesses and take investors’ questions.
Interested parties who wish to listen to the webcast should visit the “Investors & Media” section of either www.applera.com or www.celera.com, or the “Investors” section of www.appliedbiosystems.com. It is suggested that listeners access the live webcast 15 minutes before it is scheduled to begin. The webcast replay will be archived on the Presentations page of the Investors section of each website.
About Applera Corporation
Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems’ products also serve the needs of some markets outside of life science research, which we refer to as “applied markets,” such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, for example in food and the environment. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.9 billion during fiscal 2006. The Celera Group is primarily a molecular diagnostics business that is using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers, and is developing diagnostic products based on these markers as well as other known markers. Celera maintains a strategic alliance with Abbott for the development and commercialization of molecular, or nucleic acid-based, diagnostic products, and it is also developing new diagnostic products outside of this alliance. Through its genomics and proteomics research efforts, Celera is also discovering and validating therapeutic targets, and it is seeking strategic partnerships to develop therapeutic products based on these discovered targets. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com.
